Blis sees 'modest' earnings surplus after more than doubling first-half sales

Blis sees 'modest' earnings surplus after more than doubling first-half sales
Paul McBeth
By Paul McBeth Oct. 14 (BusinessDesk) - Blis Technologies, which sells probiotic products targeted at oral health, colds and flu, expects to post "modest" earnings after more than doubling first-half sales, which it anticipates will flow into the annual result. The Dunedin-based company will report a "modest surplus" in earnings before interest, tax, depreciation and amortisation and a small net loss in the six months ended Sept. 30 after lifting sales 139 percent to $2.7 million, it said in a statement after the close of trading. That is...